CARA Cara Therapeutics
- 0.778
- +0.006+0.78%
- 0.772
- -0.007-0.85%
Cara Therapeutics News
Bearish Sentiment Across The Cannabis Space - Check Full Movers For April 29, 2024
GAINERS:Rocky Mountain High (OTC:RMHB) shares closed up 39.00% at $0.01Target Group (OTC:CBDY) shares closed up 32.76% at $0.01Greenlane Hldgs (NASDAQ:GNLN) shares closed up 14.76% at $0.71Global Comp
Marijuana Stock Movers For April 25, 2024
GAINERS:Cannabix Technologies (OTC:BLOZF) shares closed up 35.40% at $0.44Kaya Holdings (OTC:KAYS) shares closed up 33.56% at $0.04Nextleaf Solutions (OTC:OILFF) shares closed up 22.86% at $0.10Rocky
Marijuana Stock Movers For April 23, 2024
GAINERS:Target Group (OTC:CBDY) shares closed up 28.89% at $0.01SOL Glb Inv (OTC:SOLCF) shares closed up 26.67% at $0.04Cannabix Technologies (OTC:BLOZF) shares closed up 18.33% at $0.29Aurora Cannabi
12 Health Care Stocks Moving In Monday's After-Market Session
GainersNuwellis (NASDAQ:NUWE) stock rose 46.8% to $0.48 during Monday's after-market session. The company's market cap stands at $3.2 million. Sensei Biotherapeutics (NASDAQ:SNSE) stock rose 7.42% to
Investors Don't See Light At End Of Cara Therapeutics, Inc.'s (NASDAQ:CARA) Tunnel And Push Stock Down 26%
The Cara Therapeutics, Inc. (NASDAQ:CARA) share price has softened a substantial 26% over the previous 30 days, handing back much of the gains the stock has made lately. For any long-term sharehold
Bearish Sentiment Across The Cannabis Space - Check Full Movers For April 18, 2024
GAINERS:SOL Glb Inv (OTC:SOLCF) shares closed up 38.57% at $0.03MJ Holdings (OTC:MJNE) shares closed up 27.91% at $0.01Canopy Gwth (NASDAQ:CGC) shares closed up 20.34% at $7.83Global Compliance (OTC:F
Bearish Monday For Marijuana Stocks - AusCann Group Holdings, Target Group Among Top Gainers
GAINERS:Target Group (OTC:CBDY) shares closed up 26.37% at $0.01Greenlane Hldgs (NASDAQ:GNLN) shares closed up 17.52% at $0.70Mexco Energy (AMEX:MXC) shares closed up 16.17% at $16.38Zoned Props (OTC:
Buy Rating Affirmed for Cara Therapeutics: Promising Prospects for Oral Difelikefalin in Notalgia Paresthetica Treatment
Needham: Reiterates Cara Therapeutics (CARA.US) rating and adjusted from buy to buy rating, target price of $5.00.
Needham: Reiterates Cara Therapeutics (CARA.US) rating and adjusted from buy to buy rating, target price of $5.00.
Buy Rating Affirmed for Cara Therapeutics Amidst Promising Korsuva Ph 2/3 Program and Market Potential
Marijuana Stock Movers For April 8, 2024
GAINERS:GreenGro Technologies (OTC:GRNH) shares closed up 9900.00% at $0.0001AusCann Group Holdings (OTC:ACNNF) shares closed up 387.78% at $0.02Target Group (OTC:CBDY) shares closed up 25.75% at $0.0
Bullish Sentiment Across The Cannabis Space - Check Full Movers For April 5, 2024
GAINERS:MPX International (OTC:MPXOF) shares closed up 199900.00% at $0.0022nd Century Group (NASDAQ:XXII) shares closed up 110.81% at $3.56Global Hemp Group (OTC:GBHPF) shares closed up 86.67% at $0.
Cannabis Stock Movers For April 4, 2024
GAINERS:Choom Holdings (OTC:CHOOF) shares closed up 39900.00% at $0.0004Target Group (OTC:CBDY) shares closed up 11.21% at $0.00Heritage Cannabis Holding (OTC:HERTF) shares closed up 11.11% at $0.00Au
Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
STAMFORD, Conn., April 02, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a development-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of pat
Marijuana Stock Movers For March 29, 2024
GAINERS:GreenGro Technologies (OTC:GRNH) shares closed up 9900.00% at $0.0001CordovaCann (OTC:LVRLF) shares closed up 97.16% at $0.09Elixinol Wellness (OTC:ELLXF) shares closed up 48.21% at $0.00Rocky
Demystifying Cara Therapeutics: Insights From 4 Analyst Reviews
Throughout the last three months, 4 analysts have evaluated Cara Therapeutics (NASDAQ:CARA), offering a diverse set of opinions from bullish to bearish.The table below offers a condensed view of their
Analysts Are Bullish on These Healthcare Stocks: Celcuity (CELC), Cara Therapeutics (CARA)
Needham Reiterates Buy on Cara Therapeutics, Maintains $5 Price Target
Needham analyst Joseph Stringer reiterates Cara Therapeutics with a Buy and maintains $5 price target.
Cannabis Stock Gainers And Losers From March 27, 2024
GAINERS:Canopy Gwth (NASDAQ:CGC) shares closed up 30.57% at $9.55Maple Leaf Green World (OTC:MGWFF) shares closed up 23.64% at $0.05Cara Therapeutics (NASDAQ:CARA) shares closed up 19.15% at $0.874Fro
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersApollomics (NASDAQ:APLM) stock rose 10.9% to $0.61 during Tuesday's after-market session. The market value of their outstanding shares is at $54.5 million. Cara Therapeutics (NASDAQ:CARA) share
Analysis
Price Target
No Data
